IRS Code 280E

On Friday, the Internal Revenue Service (IRS) issued a reminder that marijuana remains classified as a Schedule I controlled substance and is thus subject to the limitations of the Internal Revenue Code, specifically Section 280E. Current Tax Rules Remain Unchanged In a press release, the IRS...

Following the recent move on the part of the DEA toward  reclassifying cannabis from Schedule I to Schedule III, Zuanic & Associates hosted discussions with industry leaders to assess the impact and outline the next steps. The comprehensive review indicates there could be ...

A recent report by Viridian Capital Advisors explores the valuation and growth prospects of cannabis stocks against those of well-established sectors like alcohol, tobacco, pharmaceuticals, healthcare products and food. The report looks closely at the value and growth of...

The Benzinga Cannabis Capital Conference recently hosted a panel discussion on financial innovation in the cannabis industry, featuring industry experts who shared valuable insights on how to enhance and sustain cannabis businesses. The panel, moderated by Katie Catanese partner at Foley &...

“I think the taxation structure makes it extremely difficult to make money given the impact of that,” said Seth Yakatan, co-founder at Katan Associates, during a dynamic Benzinga Cannabis Capital Conference panel discussion on the challenges and evolving landscape of the cannabis...

In a potentially game-changing decision, the Department of Health and Human Services (HHS) recently recommended the DEA to consider reclassifying cannabis from its Schedule I status — a classification that denotes no medical value, on par with substances like heroin — to...

“Everybody thinks it’s just around the corner. It’s going to happen. Just wait a few more months,” pointed out Anthony Coniglio, founder, president and CIO of NewLake Capital Partners Inc. (OTCQX: NLCP) during a discussion at the Benzinga Cannabis Capital...

The intricate web of politics, priorities and pressures in the Senate and House is set to make this fall's legislative session a captivating one. Legislative Focus At the heart of the Senate's bipartisan ambitions is the Secure and Fair Enforcement (SAFE) Banking Act. Senate Banking...

"It's not if, it's just when," said Kim Rivers, CEO of Trulieve Cannabis Corp (OTCQX: TCNNF), regarding the recent recommendation by the Health and Human Services Department (HHS) to the Drug Enforcement Administration (DEA) regarding the rescheduling of cannabis. In a recent...

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...

The potential of rescheduling and removing Tax Rule 280E could boost profits for U.S. businesses. However, Zuanic and Associates' latest report reveals complexities and overlooked consequences. What is the best option for unlocking the cannabis industry's potential: exploring...

Will the rescheduling of cannabis fuel a boom in cannabis stocks? Analysts from Z&A delve into the pros and cons of MSOs and cannabis rescheduling in their latest equity research report. Re-scheduling Vs. De-scheduling: What Is The Difference? Re-scheduling cannabis refers to the process of...

Section 280e of the Internal Revenue Code has emerged as an unexpected catalyst, potentially injecting a staggering $700 million boost into cash flow for major cannabis companies. The cannabis industry has faced numerous challenges, including falling prices, excessive debt and stagnant sales...

Connecticut and Illinois recently made significant moves to show their support for marijuana industries by enacting tax relief via their budget legislation. What's News? Connecticut Gov. Ned Lamont (D) signed a bill to provide state-level tax relief for licensed marijuana...